Obstet Gynecol Sci.  2020 Jul;63(4):534-537. 10.5468/ogs.19232.

Retroperitoneal Erdheim-Chester disease without skeletal bone involvement mimicking uterine sarcoma with multiple organ involvement

Affiliations
  • 1Department of Obstetrics and Gynecology, School of Medicine, Kyungpook National University, Daegu, Korea
  • 2Department of Obstetrics and Gynecology, Kyungpook National University Chilgok Hospital, Daegu, Korea
  • 3Department of Pathology, School of Medicine, Kyungpook National University, Daegu, Korea

Abstract

Erdheim-Chester disease (ECD) is a rare type of non-Langerhans cell histiocytosis and is characterized by the diffuse histiocytic infiltration of multiple organs. Retroperitoneal ECD, especially with uterine involvement, is extremely rare. We report about a 73-year-old woman who presented with vaginal spotting for a month and experienced abdominal pain along with pus-like urine. Computed tomography revealed an irregular mass-like lesion in the uterus, possibly a uterine sarcoma, invading the ureter, rectosigmoid, and bladder. A tissue biopsy of the retroperitoneal mass revealed typical morphological and immunohistochemical features of ECD. However, clinical features, especially long bone involvement, did not coincide with ECD, and BRAF V600E gene mutation was not detected. We made a diagnosis of atypical retroperitoneal ECD mimicking uterine sarcoma with multiple organ involvement.

Keyword

Erdheim-Chester disease; Uterus; Ureter

Figure

  • Fig. 1. (A) Magnetic resonance image showing a lobulated irregular mass (white arrow) at the left side of the uterus (U: uterus). (B) Magnetic resonance image showing bladder invasion (white arrow) and rectosigmoid invasion (yellow arrow). (C) Computed tomographic image showing severe hydronephrosis and hydroureter (white arrow).

  • Fig. 2. (A) Image of histopathologic features of the uterus demonstrating clear and foamy histiocytes (hematoxylin and eosin stain, ×200). (B) Immunohistochemical staining image demonstrating the strong positive reactivity of histiocytic markers (CD68, ×40).


Reference

References

1. Favara BE, Feller AC, Pauli M, Jaffe ES, Weiss LM, Arico M, et al. Contemporary classification of histiocytic disorders. Med Pediatr Oncol. 1997; 29:157–66.
Article
2. Campochiaro C, Tomelleri A, Cavalli G, Berti A, Dagna L. Erdheim-Chester disease. Eur J Intern Med. 2015; 26:223–9.
Article
3. Haroche J, Arnaud L, Amoura Z. Erdheim-Chester disease. Curr Opin Rheumatol. 2012; 24:53–9.
Article
4. Mazor RD, Manevich-Mazor M, Shoenfeld Y. ErdheimChester disease: a comprehensive review of the literature. Orphanet J Rare Dis. 2013; 8:137.
Article
5. Salama H, Kojan S, Abdulrahman S, Azzumeea F, Alhejazi A. Erdheim-Chester disease with no skeletal bone involvement and massive weight loss. Case Rep Hematol. 2017; 2017:3862052.
Article
6. Emile JF, Diamond EL, Hélias-Rodzewicz Z, Cohen-Aubart F, Charlotte F, Hyman DM, et al. Recurrent RAS and PIK3CA mutations in Erdheim-Chester disease. Blood. 2014; 124:3016–9.
Article
7. Estrada-Veras JI, O’Brien KJ, Boyd LC, Dave RH, Durham B, Xi L, et al. The clinical spectrum of Erdheim-Chester disease: an observational cohort study. Blood Adv. 2017; 1:357–66.
Article
8. Nikpanah M, Kim L, Mirmomen SM, Symons R, Papageorgiou I, Gahl WA, et al. Abdominal involvement in Erdheim-Chester disease (ECD): MRI and CT imaging findings and their association with BRAFV600E mutation. Eur Radiol. 2018; 28:3751–9.
Article
9. Diamond EL, Dagna L, Hyman DM, Cavalli G, Janku F, Estrada-Veras J, et al. Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease. Blood. 2014; 124:483–92.
Article
10. Blanco C, Fernández F, Buelta L, Garijo F, Val-Bernal JF, Sánchez S. Xanthomatous endometritis. Appl Pathol. 1989; 7:273–6.
11. Pan LY, Offman SL, Warnke RA, Longacre TA. Uterine Rosai-Dorfman disease (sinus histiocytosis with massive lymphadenopathy). Int J Gynecol Pathol. 2014; 33:432–6.
Article
Full Text Links
  • OGS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr